Cancer
-
DNA clue to child brain tumour success
DNA testing might help identify children with brain tumours that will respond to adult medications, British researchers have reported. Read more
-
PARP mutation latest personalisation possibility
British researchers have found a mutation that prevents PARP inhibitors from working, it has been announced. Read more
-
Disappointing breast cancer drug may accelerate cancer cell growth
A drug developed to treat breast cancer can accelerate cancer cell growth in some situations, a new study has revealed. Read more
-
Carboplatin effective when BRCA gene present
Women with advanced ‘triple-negative’ breast cancer and BRCA gene mutations respond better to the chemotherapy drug carboplatin than standard treatment, according to the findings of a major clinical trial published last night. Read more
-
New alarm at rising cancer drug costs
The cost of anti-cancer drugs has been increasing at a significantly greater rate than their clinical benefits, according to a new analysis. Read more
-
Women reject preventative tamoxifen
Most women with family history of breast cancer will refuse to take tamoxifen as a prophylactic, researchers warn today. Read more
-
Backing for ultrahypofractionated radiotherapy
Ultrahypofractionated radiotherapy is safe and effective for prostate cancer patients, a European conference will hear today. Read more
-
Handgrip test for lung cancer survival chances
Testing handgrip strength can help predict the survival chances of patients with non-small cell lung cancer, a conference will hear this weekend. Read more
-
NHS genomics project “at risk” – MPs
Ambitious plans to make the NHS a world leader in genomics are at risk, MPs warn today. Read more
-
New drug targets for prostate cancer
Landmark research into prostate cancer has revealed 80 molecular ‘weaknesses’ that could be targeted by drugs, it was announced last night. Read more
